NASDAQ:IMV
Delisted
IMV Inc. Stock News
$0.82
+0 (+0%)
At Close: Jul 27, 2023
IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
11:05am, Thursday, 21'st May 2020
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced positive precl
IMV INC (IMV) Reports Q1 Loss, Tops Revenue Estimates
12:25pm, Friday, 15'th May 2020
IMV INC (IMV) delivered earnings and revenue surprises of -27.27% and 27.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results
11:05am, Friday, 15'th May 2020
IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results
Analysts Estimate IMV INC (IMV) to Report a Decline in Earnings: What to Look Out for
04:30pm, Thursday, 07'th May 2020
IMV INC (IMV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IMV Inc. Announces Closing of $25.1 Million Private Placement
02:16pm, Thursday, 07'th May 2020
IMV INC. ANNOUNCES CLOSING OF $25.1 MILLION PRIVATE PLACEMENT
IMV Inc. to Announce First Quarter 2020 Results and Host a Conference Call and Webcast on May 15, 2020
11:05am, Monday, 04'th May 2020
IMV Inc. to Announce First Quarter 2020 Results and Host a Conference Call and Webcast on May 15, 2020
Vaccine Candidate to Prevent COVID-19: Fonds de solidarit FTQ to Invest $7.5 Million in IMV
11:10am, Thursday, 30'th Apr 2020
A co‑lead investor with Lumira Ventures in this financing round, the Fonds has been a partner of IMV since February 2018 . IMV, whose management team is based in Québec, is currently working on a
IMV Announces Proposed $22.3 Million Private Placement
11:05am, Thursday, 30'th Apr 2020
IMV Announces Proposed $22.3 Million Private Placement
IMV to Participate in Adelaide Capital’s Virtual COVID & Healthcare Mini Conference
09:05pm, Tuesday, 21'st Apr 2020
IMV to participate in Adelaide Capital’s Virtual COVID & Healthcare Mini Conference
Does IMV (TSE:IMV) Have A Healthy Balance Sheet?
12:13pm, Saturday, 04'th Apr 2020
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
FY2020 EPS Estimates for Imv Inc Lowered by Raymond James (NYSE:IMV)
08:54am, Saturday, 04'th Apr 2020
Imv Inc (NYSE:IMV) – Equities research analysts at Raymond James reduced their FY2020 earnings per share (EPS) estimates for IMV in a report issued on Tuesday, March 31st. Raymond James analyst D. N
Oppenheimer Thinks IMV’s Stock is Going to Recover
09:01am, Thursday, 02'nd Apr 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on IMV (IMV – Research Report) on March 31 and set a
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development
09:59pm, Wednesday, 01'st Apr 2020
The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development
09:59pm, Wednesday, 01'st Apr 2020
The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Why Did B.Riley FBR Downgrade IMV’s Stock?
04:58pm, Tuesday, 31'st Mar 2020
IMV (
IMV
–
Research Report
) received a
Hold
rating and a
$3.00
price target from B.Riley FBR analyst
Mayank Mamtani
today. The company’s shares closed last Tuesday at $1.60, close to its 52-week
